Table 2. The pooled prevalence of domains of RMC in Ethiopia, 2022.
Domains of RMC with a list of studies | Sample size | Pooled prevalence(95% CI) | Heterogeneity | P-value | |
---|---|---|---|---|---|
I2 | Cochran’s Q | ||||
Friendly care | 3175 | 49.99 (32.46,67.52) | 99.2 | 899.01 | 0<0.001 |
Amsalu et al., 2022 [21] | |||||
Yismaw et al., 2022 [23] | |||||
Adane et al., 2021 [25] | |||||
Ambachew, 2021 [26] | |||||
Bante et al., 2020 [30] | |||||
Bulto et al., 2020 [31] | |||||
Yosef et al., 2020 [32] | |||||
Wassihun and Zeleke, 2018 [35] | |||||
Abuse-free care | 3958 | 58.36(46.44,70.29) | 98.5 | 537.34 | 0<0.001 |
Amsalu et al., 2022 [21] | |||||
Yismaw et al., 2022 [23] | |||||
Adane et al., 2021 [25] | |||||
Ambachew, 2021 [26] | |||||
Wochefu et al, 2021 [29] | |||||
Bante et al., 2020 [30] | |||||
Bulto et al., 2020 [31] | |||||
Yosef et al., 2020 [32] | |||||
Wassihun and Zeleke, 2018 [35] | |||||
Timely care | 3958 | 68.95(64.52, 73.38) | 89.4 | 75.82 | 0<0.001 |
Amsalu et al., 2022 [21] | |||||
Yismaw et al., 2022 [23] | |||||
Adane et al., 2021 [25] | |||||
Ambachew, 2021 [26] | |||||
Wochefu et al, 2021 [29] | |||||
Bante et al., 2020 [30] | |||||
Bulto et al., 2020 [31] | |||||
Yosef et al., 2020 [32] | |||||
Wassihun and Zeleke, 2018 [35] | |||||
Discrimination- free care | 3958 | 78.53(72.57, 84.48) | 96.1 | 207.03 | 0<0.001 |
Amsalu et al., 2022 [21] | |||||
Yismaw et al., 2022 [23] | |||||
Adane et al., 2021 [25] | |||||
Ambachew, 2021 [26] | |||||
Wochefu et al, 2021 [29] | |||||
Bante et al., 2020 [30] | |||||
Bulto et al., 2020 [31] | |||||
Yosef et al., 2020 [32] | |||||
Wassihun and Zeleke, 2018 [35] |